ResearchIntegrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
ResearchAssociation of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy
ResearchDifferential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer
ResearchPrediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity
ResearchLimitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
ResearchTumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer
ResearchCharacterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials
ResearchRepresentation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
ResearchMethicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy